miragentherapeutics.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
Meta Tags
| Title | Corporate Profile | Viridian Therapeutics, |
| Description | Investors Corporate Profile Press Releases Events Presentations Corporate Governance Leadership Committee Composition Financials and Filings Stock Information Infor |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 3.33.152.147 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
miragentherapeutics.com Valuation
|
US$830
Last updated: 2022-09-17 23:33:07
miragentherapeutics.com has Semrush global rank of 0. miragentherapeutics.com has an estimated worth of US$ 830, based on its estimated Ads revenue. miragentherapeutics.com receives approximately 95 unique visitors each day. Its web server is located in United States, with IP address 3.33.152.147. According to SiteAdvisor, miragentherapeutics.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$830 |
| Daily Ads Revenue | US$0 |
| Monthly Ads Revenue | US$23 |
| Yearly Ads Revenue | US$276 |
| Daily Unique Visitors | 6 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| miragentherapeutics.com. 599 | A | miragentherapeutics.com. 599 | IP: 3.33.152.147 |
| miragentherapeutics.com. 599 | A | miragentherapeutics.com. 599 | IP: 15.197.142.173 |
| miragentherapeutics.com. 3600 | NS | miragentherapeutics.com. 3600 | NS Record: ns54.domaincontrol.com. |
| miragentherapeutics.com. 3600 | NS | miragentherapeutics.com. 3600 | NS Record: ns53.domaincontrol.com. |
| miragentherapeutics.com. 3600 | MX | miragentherapeutics.com. 3600 | MX Record: 0 miragentherapeutics-com.mail.protection.outlook.com. |
| miragentherapeutics.com. 600 | TXT | miragentherapeutics.com. 600 | TXT Record: v=spf1 include:spf.protection.outlook.com include:ip4:50.203.96.214 include:ip4:50.203.97.84 include:spf.emailsignatures365.com include:email.freshservice.com -all |
| miragentherapeutics.com. 600 | TXT | miragentherapeutics.com. 600 | TXT Record: google-site-verification=1idlDOSPuezYoZMPgKN70XKIuJzfo5IsClhZZxEMEAE |
| miragentherapeutics.com. 600 | TXT | miragentherapeutics.com. 600 | TXT Record: google-site-verification=EpyHwBTd6rPu76tEWk_SMXr2zc9zLn7pPF0SfK8crlY |
| miragentherapeutics.com. 600 | TXT | miragentherapeutics.com. 600 | TXT Record: google-site-verification=rMRg5U7xZdiHemcuPiSgyU9wrNm2Gj3gnBATDC3d_-c |
| miragentherapeutics.com. 600 | TXT | miragentherapeutics.com. 600 | TXT Record: v=verifydomain MS=ms66991872 |
| miragentherapeutics.com. 600 | TXT | miragentherapeutics.com. 600 | TXT Record: miragencorpwordpress.azurewebsites.net |
HtmlToTextCheckTime:2022-09-17 23:33:07
| Corporate Profile Press Releases Events Presentations Corporate Governance Leadership Committee Composition Financials and Filings Stock Information Information Request Email Notification menu close x About Company Leadership Collaborations --> Contact --> Programs Pipeline Out-Licensing Development Strategy --> Clinical Trials --> Science microRNA Platform Therapeutic Areas Scientific Publications --> Careers Culture & Values Job Openings Investors Patients Clinical Trials Overview Cutaneous T-Cell Lymphoma (CTCL) Adult T-Cell Lymphoma/Leukemia (ATLL) Diffuse Large B-Cell Lymphoma (DLBCL) Chronic Lymphocytic Leukemia (CLL) Keloids --> Clinicians viridiantherapeutics Clinical Trials Cutaneous T-cell Lymphoma (CTCL), MF Subtype – Cobomarsen SOLAR Clinical Trial ATLL, CLL and DLBCL – Cobomarsen Phase 1 Clinical Trial Keloids – Remlarsen Phase 2 Clinical Trial --> Contact Investors Follow Viridian Therapeutics @ViridianThera ViridianTx Contact Viridian Therapeutics |
HTTP Headers
HTTP/1.1 405 Not Allowed Server: awselb/2.0 Date: Sat, 25 Dec 2021 09:47:46 GMT Content-Length: 0 Connection: keep-alive WAFRule: HTTPMethodNOTAllowed |
miragentherapeutics.com Whois Information
Domain Name: MIRAGENTHERAPEUTICS.COM Registry Domain ID: 1140707024_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2018-08-13T17:11:59Z Creation Date: 2007-08-08T21:17:34Z Registry Expiry Date: 2023-08-08T21:17:34Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS53.DOMAINCONTROL.COM Name Server: NS54.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2021-12-29T07:45:34Z <<< |